Imaging of Uveitis Patients Receiving Injectable Fluocinolone Acetonide Implant

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

August 8, 2019

Primary Completion Date

January 1, 2026

Study Completion Date

March 1, 2026

Conditions

Uveitis

Interventions

DRUG

Fluocinolone Acetonide

Injection of fluocinolone acetonide implant will be injected as standard of care treatment for patients with active uveitis.

Trial Locations (1)

RECRUITING

Cole Eye Institute Cleveland Clinic Foundation, Cleveland

All Listed Sponsors

lead

The Cleveland Clinic

OTHER